DrugDashboards

Metoprolol Succinate

Metoprolol Succinate ER Tablets · METOPROLOL SUCCINATE 200 mg/1 · Tablet, Film Coated, Extended Release · Oral · Ascend Laboratories, LLC

NDC 67877-0593-05 · 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.1870 per unit over the past year. A Class II recall hit this product in the past year (Ascend Laboratories, LLC). Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1870per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.1825per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.1870per TABweighted avg manufacturer price $0.0753 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2$0.3May 2025Sep 2026$0.187
17 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$5.61
#90 count
$16.83

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

15● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • Class I/II recall in past 12 months+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for metoprolol succinate er tablets (oral solid) in the next 90 days

sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA211143
TE code
AB
Approval date
Nov 25, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingApr 27, 2026
    Ascend Laboratories, LLC — Failed Dissolution Specifications
  • Class II · TerminatedJan 5, 2023
    Ascend Laboratories, LLC — Failed Dissolution Specification
  • Class II · TerminatedJan 5, 2023
    Ascend Laboratories, LLC — Failed Dissolution Specification
  • Class II · TerminatedJan 5, 2023
    Ascend Laboratories, LLC — Failed Dissolution Specification
  • Class II · TerminatedJan 12, 2022
    Ascend Laboratories, LLC — Failed Dissolution Specifications.

Manufacturers of Metoprolol Succinate ER Tablets (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackMETOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCMETOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesMETOPROLOL SUCCINATE 200 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPMETOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.METOPROLOL SUCCINATE 25 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.METOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsMETOPROLOL SUCCINATE 50 mg/1Jul 15, 2026Aug 31, 2026
Bryant Ranch PrepackMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Aug 31, 2026
A-S Medication SolutionsMETOPROLOL SUCCINATE 100 mg/1Jul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Metoprolol Succinate — NDC 67877-0593-05," retrieved September 3, 2026, https://drugdashboards.com/drug/67877059305.

Free to cite with attribution — see how the data is put together.